Company Search:
Advanced Search
Sponsored Links
Grindeks AS Company Snapshot
Grindeks AS operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Grindeks AS with three other pharmaceutical manufacturers in Europe: Dottikon ES Holding AG of Switzerland (2017 sales of 151.75 million Swiss Francs [US$157.09 million] of which 89% was Pharma Products), Opus Global Nyrt of Hungary (42.59 billion Hungarian Forints [US$169.52 million] ), and Olainfarm AS (122.08 million Euro [US$151.09 million] ).

Sales Analysis. During the year ended December of 2017, sales at Grindeks AS were 132.41 million Euro (US$163.87 million). This is an increase of 25.7% versus 2016, when the company's sales were 105.37 million Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Grindeks AS
  Stock Performance Chart for Grindeks AS
  Stock Data: Recent Stock Performance:
  Current Price (4/13/2018): 7.48
(Figures in Euro)
1 Week -0.3%   13 Weeks 0.0%  
4 Weeks 3.9%   52 Weeks 43.6%  
Grindeks AS Key Data:
  Ticker: GRD1R Country: Latvia
  Exchanges: Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 132,410,851
(Year Ending Jan 2018).
Employees: 847
  Currency: Euro Market Cap: 71,695,800
  Fiscal Yr Ends: December Shares Outstanding: 9,585,000
  Share Type: Closely Held Shares: 4,786,750
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.